Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
ORIGINAL ARTICLE
Year : 2015  |  Volume : 28  |  Issue : 4  |  Page : 793-799

Glyceryl trinitrate for prevention of pancreatitis after endoscopic retrograde cholangiopancreatography: meta-analysis of randomized, controlled trials


Department of General Surgery, Faculty of Medicine, Menoufia University, Menoufia, Egypt

Correspondence Address:
Haith A Mukhtar
Al Mahalla El Kobra, 317811
Egypt
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/1110-2098.173584

Rights and Permissions

Objective The aim of the study was to conduct a meta-analysis of published, full-length, randomized controlled trials (RCTs) evaluating the effect of prophylactic glyceryl trinitrate (GTN) on the prevention of pancreatitis after endoscopic retrograde cholangiopancreatography (PEP) and the prevention of hyperamylasemia. Data sources Literature searches were conducted using PubMed, EMBASE, The Cochrane Library, and Web of Knowledge databases (up to May 2014) using keywords 'post-ERCP', 'pancreatitis', 'ERCP', 'post endoscopic retrograde cholangiopancreatography pancreatitis', 'GTN', 'glyceryl trinitrate', and 'nitroglycerin', and were limited to RCTs. No language restriction was imposed. Study selection The following selection criteria were applied: (i) study design - RCTs; (ii) study population - patients undergoing endoscopic retrograde cholangiopancreatography (ERCP); (iii) intervention - prophylactic administration of GTN; (iv) comparison intervention - control or no treatment; and (v) outcome measures - the overall incidence of PEP, the incidence of moderate to severe PEP, the incidence of hyperamylasemia, and the incidence of adverse effect with prophylactic use of GTN. Data extraction Data from eligible studies were extracted independently by using standard forms. Details of the studies included name of the first author, year of publication, country, setting, sample size, interventions, dosage, follow-up, routes of drug administration, inclusion and exclusion criteria of each study, definition, incidence of PEP (including overall and moderate to severe pancreatitis, respectively) and hyperamylasemia. Data synthesis All statistical analyses were performed using Comprehensive Meta-analysis Version 2. All outcomes were expressed as odds ratio (OR) with 95% confidence interval (CI). Findings Eleven randomized controlled trials (RCTs) involving 2395 patients were included. Eleven RCTs compared GTN with placebo for PEP prevention. Meta-analysis showed that the overall incidence of PEP was significantly reduced by GTN treatment (OR 0.65, 95% CI 0.483-0.784). Nevertheless, GTN administration did not decrease the incidence of moderate to severe PEP (OR 0.687, 95% CI 0.407-1.16). Subgroup analyses revealed that GTN administered sublingually was more effective than transdermal and topical administration in reducing the incidence of PEP. In addition, the incidence of hyperamylasemia was significantly reduced by GTN treatment (OR 0.483, 95% CI 0.289-0.809).


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed862    
    Printed15    
    Emailed0    
    PDF Downloaded3178    
    Comments [Add]    

Recommend this journal